Akouos Operating Expenses 2011-2026 | AKUS

Annual Operating Expenses Akouos

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
86.8 M	48.9 M	23.9 M	7.42 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
86.8 M	7.42 M	41.8 M

Quarterly Operating Expenses Akouos

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	20.2 M	21 M	27 M	-	27 M	22.8 M	16.1 M	-	13.1 M	12.6 M	10.5 M	-	5.26 M	5.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
27 M	5.12 M	16.4 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	231 M	$ 1.61	-2.73 %	$ 189 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Celldex Therapeutics CLDX	58.1 M	$ 31.72	0.05 %	$ 2.11 B	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
BioNTech SE BNTX	512 M	$ 96.94	3.75 %	$ 23.4 B	Germany
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
CRISPR Therapeutics AG CRSP	668 M	$ 55.72	-1.17 %	$ 5.01 B	Schweiz
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Compugen Ltd. CGEN	32.2 M	$ 2.69	-3.24 %	$ 251 M	Israel
Abcam plc ABCM	170 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Enlivex Therapeutics Ltd. ENLV	15 M	$ 0.82	6.92 %	$ 37.5 M	Israel
Affimed N.V. AFMD	54 M	-	-34.95 %	$ 21.5 M	Germany
Esperion Therapeutics ESPR	343 M	$ 3.14	0.16 %	$ 653 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 30.72	-3.58 %	$ 827 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Forte Biosciences FBRX	70.7 M	$ 19.3	-7.08 %	$ 250 M	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.54	-1.17 %	$ 162 M	USA
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
IMV IMV	35.1 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Grifols, S.A. GRFS	1.64 B	$ 7.93	-0.63 %	$ 5.39 B	Spain
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	98.4 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	214 M	-	-	$ 3.37 B	China
Heron Therapeutics HRTX	281 M	$ 0.87	-2.33 %	$ 145 M	USA
ImmuCell Corporation ICCC	9.8 M	$ 10.11	2.12 %	$ 91.3 M	USA
Anika Therapeutics ANIK	51.6 M	$ 14.71	-1.28 %	$ 211 M	USA
Advaxis ADXS	19.6 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 3.38	-1.46 %	$ 5.56 M	Israel
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada